Gradientech
Gradientech is a Swedish in vitro diagnostics company dedicated to supporting modern microbiology labs with cutting-edge solutions for time-critical samples, such as positive blood cultures. Their mission is to develop next-generation diagnostics that provide patients with the right treatment at the right time, supporting clinicians with precise MIC values in record time to improve patient outcomes and reduce healthcare costs and antibiotic resistance. Their vision is "Precision medicine, for a sustainable world." They develop innovative, high-quality, easy-to-use products, including the QuickMIC system, which offers ultra-rapid antibiotic susceptibility testing results in 2-4 hours. The company is committed to quality, sustainability, and advancing healthcare through innovative diagnostics.
Industries
Nr. of Employees
medium (51-250)
Products
Ultra-rapid AST instrument system
A compact diagnostic instrument platform and single-use test cassettes for rapid phenotypic antibiotic susceptibility testing that yields MIC values in approximately 2–4 hours directly from positive blood cultures.
Ultra-rapid AST instrument system
A compact diagnostic instrument platform and single-use test cassettes for rapid phenotypic antibiotic susceptibility testing that yields MIC values in approximately 2–4 hours directly from positive blood cultures.
Services
Clinical study coordination and validation
Coordination and execution of multicenter clinical and pre-clinical studies to generate evidence for regulatory approvals and clinical adoption.
Installation and implementation support
Field implementation, instrument installation and local evaluations with distributor partners at clinical sites.
Clinical study coordination and validation
Coordination and execution of multicenter clinical and pre-clinical studies to generate evidence for regulatory approvals and clinical adoption.
Installation and implementation support
Field implementation, instrument installation and local evaluations with distributor partners at clinical sites.
Expertise Areas
- Antibiotic susceptibility testing (phenotypic AST)
- Clinical trial management for diagnostics (multicenter and regulatory studies)
- Regulatory compliance for in vitro diagnostics (CE-IVD, IVDR, FDA interactions)
- Microfluidics research and platform development
Key Technologies
- Phenotypic AST directly from blood cultures
- Real-time microscopic/live imaging and image analysis
- Microfluidic diagnostic platforms
- Machine learning algorithms for resistance detection